30,000 Shares in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Acquired by AlphaCore Capital LLC

AlphaCore Capital LLC acquired a new position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) in the third quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 30,000 shares of the pharmacy operator’s stock, valued at approximately $269,000.

Several other large investors have also recently added to or reduced their stakes in the stock. Iron Horse Wealth Management LLC raised its stake in Walgreens Boots Alliance by 162.5% during the 2nd quarter. Iron Horse Wealth Management LLC now owns 2,100 shares of the pharmacy operator’s stock valued at $25,000 after acquiring an additional 1,300 shares in the last quarter. Blue Trust Inc. raised its stake in shares of Walgreens Boots Alliance by 87.0% during the second quarter. Blue Trust Inc. now owns 2,324 shares of the pharmacy operator’s stock valued at $28,000 after purchasing an additional 1,081 shares in the last quarter. Continuum Advisory LLC lifted its holdings in Walgreens Boots Alliance by 71.2% in the second quarter. Continuum Advisory LLC now owns 2,453 shares of the pharmacy operator’s stock worth $30,000 after purchasing an additional 1,020 shares during the period. Sentry Investment Management LLC bought a new position in Walgreens Boots Alliance in the 3rd quarter valued at about $30,000. Finally, Eastern Bank acquired a new position in Walgreens Boots Alliance during the 3rd quarter valued at about $33,000. 58.59% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on the stock. Jefferies Financial Group reduced their price target on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating for the company in a research note on Wednesday, October 23rd. Bank of America lowered their price target on Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating on the stock in a research report on Wednesday, September 4th. Evercore ISI lifted their target price on Walgreens Boots Alliance from $7.50 to $10.00 and gave the stock an “in-line” rating in a report on Wednesday, October 16th. JPMorgan Chase & Co. dropped their price target on shares of Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating on the stock in a research report on Friday, August 30th. Finally, TD Cowen lowered their price objective on shares of Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating on the stock in a research note on Tuesday, October 22nd. Four equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and two have assigned a buy rating to the company. According to MarketBeat, Walgreens Boots Alliance presently has a consensus rating of “Hold” and an average price target of $12.88.

View Our Latest Research Report on Walgreens Boots Alliance

Walgreens Boots Alliance Trading Up 0.4 %

WBA stock opened at $8.27 on Friday. The company has a 50 day moving average of $9.15 and a two-hundred day moving average of $11.65. Walgreens Boots Alliance, Inc. has a 12-month low of $8.08 and a 12-month high of $27.05. The company has a current ratio of 0.68, a quick ratio of 0.37 and a debt-to-equity ratio of 0.67.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last released its quarterly earnings data on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.36 by $0.03. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. The firm had revenue of $37.50 billion during the quarter, compared to analysts’ expectations of $35.75 billion. During the same quarter last year, the firm earned $0.67 earnings per share. The business’s revenue for the quarter was up 5.9% on a year-over-year basis. As a group, research analysts predict that Walgreens Boots Alliance, Inc. will post 1.53 EPS for the current year.

Walgreens Boots Alliance Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 12th. Investors of record on Monday, November 18th will be issued a $0.25 dividend. The ex-dividend date of this dividend is Monday, November 18th. This represents a $1.00 dividend on an annualized basis and a yield of 12.09%. Walgreens Boots Alliance’s dividend payout ratio is currently -9.99%.

Walgreens Boots Alliance Company Profile

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Featured Stories

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.